Related Experiment Video
Updated: May 1, 2026

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
Published on: December 15, 2023
Changes in breast cancer reports after pathology second opinion
Vicente Marco1, Teresa Muntal, Felip García-Hernandez
1Department of Pathology, Hospital Quiron Barcelona, Barcelona, Spain.
Pathology second opinions for breast cancer cases revealed significant discrepancies in 25.4% of instances. These changes in histologic classification and invasion assessment impact patient prognosis and treatment strategies.
Area of Science:
- Oncology
- Pathology
- Medical Diagnostics
Background:
- Breast cancer pathology reports are crucial for diagnosis, prognosis, and treatment response prediction.
- Second opinions are often sought for referred patients to confirm initial findings.
Purpose of the Study:
- To evaluate the impact and frequency of pathology second opinions in breast cancer cases.
- To identify types of discrepancies and their clinical significance.
Main Methods:
- Review of 205 breast cancer cases referred for a second opinion between 2002 and 2012.
- Analysis of hematoxylin-eosin preparations, paraffin blocks, and external reports.
- Performance of immunohistochemical studies for hormone receptors, HER2, and other markers.
Main Results:
- 25.4% of cases (52/205) showed changes upon second review.
- 16% (33/205) had major changes impacting prognosis or treatment.
- Key discrepancies involved histologic classification, invasion assessment, hormone receptor status, and HER2 results.
Conclusions:
- Pathology second opinions can uncover significant discrepancies in breast cancer diagnosis.
- Discrepancies frequently relate to invasion assessment, predictive markers, and differentiating breast cancer from other tumors.
- Accurate pathology review is vital for optimal patient management and prognosis.
More Related Videos
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017